Publication
Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker Diabetic Fatty rat)
| dc.contributor.author | Mega, C. | |
| dc.contributor.author | Teixeira de Lemos, E. | |
| dc.contributor.author | Vala, Helena | |
| dc.contributor.author | Fernandes, R. | |
| dc.contributor.author | Oliveira, J. | |
| dc.contributor.author | Mascarenhas-Melo, F. | |
| dc.contributor.author | Teixeira, F. | |
| dc.contributor.author | Reis, F. | |
| dc.date.accessioned | 2013-01-07T13:18:21Z | |
| dc.date.available | 2013-01-07T13:18:21Z | |
| dc.date.issued | 2011 | |
| dc.description.abstract | This study was performed to assess the effect of chronic low-dose sitagliptin, a dipeptidyl peptidase 4 inhibitor, on metabolic profile and on renal lesions aggravation in a rat model of type-2 diabetic nephropathy, the Zucker Diabetic Fatty (ZDF) rat. Diabetic and obese ZDF (fa/fa) rats and their controls ZDF (+/+) were treated for 6 weeks with vehicle (control) or sitagliptin (10 mg/kg/bw). Blood/serum glucose, HbA1c, insulin, Total-c, TGs, urea and creatinine were assessed, as well as kidney glomerular and tubulointerstitial lesions (interstitial fibrosis/tubular atrophy), using a semi-quantitative rating from 0 (absent/normal) to 3 (severe and extensive damage). Vascular lesions were scored from 0-2. Sitagliptin in the diabetic rats promoted an amelioration of glycemia, HbA1c, Total-c and TGs, accompanied by a partial prevention of insulinopenia. Furthermore, together with urea increment prevention, renal lesions were ameliorated in the diabetic rats, including glomerular, tubulointerstitial and vascular lesions, accompanied by reduced lipid peroxidation. In conclusion, chronic low-dose sitagliptin treatment was able to ameliorate diabetic nephropathy, which might represent a key step forward in the management of T2DM and this serious complication. | por |
| dc.identifier.citation | Mega C, Teixeira de Lemos E, Vala H, Fernandes R, Oliveira J, Mascarenhas-Melo F, Teixeira F, Reis F. 2011. Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker Diabetic Fatty rat). Experimental Diabetes Research. Article ID 162092: 12pp | por |
| dc.identifier.uri | http://hdl.handle.net/10400.19/1413 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.subject | type 2 diabetic nephropathy | por |
| dc.subject | sitagliptin | por |
| dc.subject | dysmetabolism | por |
| dc.subject | renal lesion | por |
| dc.subject | ZDF rat | por |
| dc.title | Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker Diabetic Fatty rat) | por |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.title | Experimental Diabetes Research | por |
| person.familyName | Vala Correia | |
| person.givenName | Helena Maria | |
| person.identifier.ciencia-id | 7A1E-E85E-FFA4 | |
| person.identifier.orcid | 0000-0001-6829-4867 | |
| rcaap.rights | restrictedAccess | por |
| rcaap.type | article | por |
| relation.isAuthorOfPublication | cdc3d2e2-df06-40ed-8900-1ecbc8a06c8a | |
| relation.isAuthorOfPublication.latestForDiscovery | cdc3d2e2-df06-40ed-8900-1ecbc8a06c8a |